Christina Martin
Family · Broken Arrow, OKNPI 1134636558
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 88 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $782 and has fallen 94.3% since, to $45 in 2025.
Across 88 payments — averaging $12.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$171
- AbbVie$146
- Lilly USA, LLC$142
- Kowa Pharmaceuticals America, Inc.$124
- GSK$101
- AstraZeneca$59
- plus $377 from 14 others
What the payments were for
- Food & beverage$1,120100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 14 | $171 |
| AbbVie | 12 | $146 |
| Lilly USA, LLC | 9 | $142 |
| Kowa Pharmaceuticals America, Inc. | 14 | $124 |
| GSK | 7 | $101 |
| AstraZeneca | 3 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $35 |
| Bayer | 2 | $34 |
| Abbott | 2 | $31 |
| Boehringer Ingelheim | 2 | $30 |
| Mayne Pharma Commercial LLC | 7 | $29 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $28 |
| Amgen | 2 | $27 |
| SK Life Science, Inc. | 1 | $27 |
| Currax Pharmaceuticals LLC | 2 | $26 |
| Merck | 2 | $25 |
| Pfizer | 1 | $15 |
| Novartis | 1 | $13 |
| Evofem Biosciences, Inc. | 1 | $12 |
How this compares
$1,120 in reported general payments places this provider in the 70th percentile of 2,026 family providers in Oklahoma.
Other family in Broken Arrow
- April WilcoxOklahoma City$245K
- Jeremy MorganOklahoma City$63K
- Samantha BellingerOklahoma City$39K
- Candy WilliamsTulsa$22K
- Lacey HillOklahoma City$20K
- Shelby WrightStillwater$17K
- Amanda OblanderYukon$17K
- Julia John SamuelOklahoma City$17K
- Jillian OakleafTulsa$15K
- Kristina SnyderOklahoma City$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.